[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362167-105":59,"doc-detail-362167-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-gut-microbiota-obesity-axis-in-the-pathogenesis-and-prognosis-of-breast-cancer","The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer","","Breast cancer remains a major global health concern, with obesity-associated metabolic dysfunction increasingly linked to gut microbiota (GM) dysbiosis. A systematic search of PubMed and Web of Science (July 2015–January 2025) examined BC–GM interactions, obesity-driven mechanisms, and GM-targeted interventions. Obesity can promote inflammation, adipokine disruption, and steroid hormone metabolism via gut-derived β-glucuronidase, activating oncogenic signaling and immunosuppressive MDSCs. Diet, probiotics, and fecal microbiota transplantation may restore barrier integrity and anti-tumor immunity, though subtype-specific microbial signatures and therapy optimization remain challenging.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-gut-microbiota-obesity-axis-in-the-pathogenesis-and-prognosis-of-breast-cancer/362167/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-gut-microbiota-obesity-axis-in-the-pathogenesis-and-prognosis-of-breast-cancer/362167.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the central focus of this review?","Question",{"text":112,"@type":113},"The review explains how the gut microbiota–obesity axis contributes to breast cancer pathogenesis and prognosis, emphasizing mechanisms linking GM dysbiosis and obesity-associated metabolic dysfunction.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What findings suggest a mechanistic link between obesity and breast cancer?",{"text":117,"@type":113},"The review describes obesity-driven systemic inflammation, altered adipokine secretion, and disrupted steroid hormone metabolism, alongside GM-derived metabolites that can activate oncogenic pathways and promote immune evasion.",{"name":119,"@type":110,"acceptedAnswer":120},"Which GM-targeted interventions are discussed as potentially beneficial?",{"text":121,"@type":113},"Dietary modulation, probiotics, and fecal microbiota transplantation are discussed as approaches that may reduce dysbiosis, strengthen gut barriers, restore anti-tumor immunity, and improve chemotherapy response while lowering recurrence risk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362167,1790666750,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","AnnAls of Medicine  \n2026, Vol. 58, no. 1, 2611203 [https://doi.org/10.1080/07853890.2025.261](https://doi.org/10.1080/07853890.2025.261)1203  \nREVIEW ARTICLE     \nThe gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer  \nHuiyue Zhanga,b, Yue Wanga,b, Benyi Ninga,b, Yiwen Wanga,b, Tao Suna,c,d and Junnan Xua,b,d adepartment of Breast Medicine 1, cancer Hospital of china Medical University, liaoning cancer Hospital, shenyang, china; bdepartment of Pharmacology, cancer Hospital of china Medical University, liaoning cancer Hospital, shenyang, china;  \ncdepartment of oncology Medicine, Key laboratory of liaoning Breast cancer Research, shenyang, china; ddepartment of Breast Medicine, cancer Hospital of dalian University of Technology, liaoning cancer Hospital, shenyang, china  \nABSTRACT  \nBackground: Breast cancer (BC) remains a major global health concern, accounting for 11.7% of all cancer cases and ranking as the second leading cause of female cancer-related deaths worldwide. Increasing evidence highlights the interplay between gut microbiota (GM) dysbiosis and obesity-associated metabolic dysfunction in BC progression. This review aims to elucidate the role of GM in obese patients with BC. Methods: A systematic literature search was conducted in PubMed and Web of Science databases for publications from July 2015 to January 2025. Search terms combined BC, GM, obesity, dysbiosis, immunity, and microbiome. Article selection prioritized studies investigating microbial alterations in BC patients, mechanistic links between obesity and cancer progression, and GM-targeted interventions. Both original studies and authoritative reviews were included, supplemented by manual reference screening. Discussion: Obesity may trigger systemic inflammation, altered adipokine secretion, and disrupted steroid hormone metabolism via gut-derived β-glucuronidase activity, thereby exacerbating BC occurrence and recurrence. GM dysbiosis-driven metabolites such as branched-chain amino acids (BCAAs) and short-chain fatty acids (SCFAs) can activate oncogenic signaling pathways and immunosuppressive myeloid-derived suppressor cells (MDSCs), fostering tumor immune evasion. Conversely, dietary interventions, probiotics, and fecal microbiota transplantation (FMT) can alleviate dysbiosis, strengthen gut barriers, and restore anti-tumor immunity, improving chemotherapy response and reducing recurrence. However, challenges persist in deciphering BC subtype-related microbial signatures and optimizing microbiota-targeted therapies.  \nConclusion: Future longitudinal studies are needed to clarify causal relationships, validate microbial biomarkers, and translate preclinical findings into clinical applications. Addressing the gut-breast axis may offer transformative potential for precision oncology in obesity-driven BC.  \nKEY MESSAGES  \nSystematic integration of gut microbiota, obesity, and breast cancer interactions. Gut dysbiosis resulting from obesity exacerbates breast cancer via immune pathways. Probiotics inhibit breast cancer, mitigate high-fat diet-induced obesity, and dietary modulation of gut microbiota metabolites improves breast cancer prognosis.  \nGlossary: AI: artificial intelligence; BFT-1: Bacteroides fragilis toxin-1; BB: blueberry extracts; BMI: body mass index; BCAAs: branched-chain amino acids; BC: breast cancer; BCSCs: breast cancer stem cells; GAK: cyclin g-associated kinase; ENL: enterolactone; ETBF: Enterotoxigenic bacteroides fragilis; FMT: fecal microbiota transplantation; FOS: fructooligosaccharides; GOS: galactooligosaccharides; GLP-1: glucagon-like peptide-1; GM: gut microbiota; HFD: high-fat diet; ICB: immune checkpoint blockade; IPA: indole-3-propionic acid; IL-6: interleukin-6; LPS: lipopolysaccharides; LCFAs: long-chain fatty acids; Ly6G+: lymphocyte antigen 6 complex locus G6D+; MDSCs: myeloid-derived suppressor cells; NOD1: nucleotide binding oligomerization domain containing 1; PMN-MDSCs: polymorphonuclear","cbCaik10GeWjauHW","https://ap.wps.com/l/cbCaik10GeWjauHW","pdf",1052712,17,"English","# Abstract\n# Introduction\n## Breast cancer incidence trends\n## Host genetic and epigenetic background\n# Key messages","[{\"question\":\"What is the central focus of this review?\",\"answer\":\"The review explains how the gut microbiota–obesity axis contributes to breast cancer pathogenesis and prognosis, emphasizing mechanisms linking GM dysbiosis and obesity-associated metabolic dysfunction.\"},{\"question\":\"What findings suggest a mechanistic link between obesity and breast cancer?\",\"answer\":\"The review describes obesity-driven systemic inflammation, altered adipokine secretion, and disrupted steroid hormone metabolism, alongside GM-derived metabolites that can activate oncogenic pathways and promote immune evasion.\"},{\"question\":\"Which GM-targeted interventions are discussed as potentially beneficial?\",\"answer\":\"Dietary modulation, probiotics, and fecal microbiota transplantation are discussed as approaches that may reduce dysbiosis, strengthen gut barriers, restore anti-tumor immunity, and improve chemotherapy response while lowering recurrence risk.\"}]","The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer | PDF",1790146632,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8747adfa1f8fda90e70d4ca623a2766d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfcdb40adec8221f5b41f93e243cbe4c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfcf5d76057e38f59ecbe181c2097c45.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e9b2fc921c92aeb2a7e2059e80debd8.webp",980,1306]